Quantum Biopharma Ltd. (QNTM) — 6-K Filings

6-K Filings (50)

• 6-K Filing — May 7, 2026
• Quantum Biopharma Files 6-K Report — Apr 2, 2026 Risk: low
  Quantum Biopharma Ltd. filed a Form 6-K on April 2, 2026, reporting information as a foreign issuer. The filing includes a press release as Exhibit 99.1. The co
• Quantum Biopharma Ltd. Files 6-K Report — Apr 1, 2026 Risk: low
  Quantum Biopharma Ltd. filed a Form 6-K on April 1, 2026, reporting information as a foreign issuer. The filing includes a press release and other documents rel
• Quantum Biopharma Files 6-K Report — Mar 30, 2026 Risk: low
  Quantum Biopharma Ltd. filed a Form 6-K on March 30, 2026, reporting its status as a foreign issuer. The filing includes a press release as Exhibit 99.1. The co
• Quantum Biopharma Files 6-K Report — Mar 27, 2026 Risk: low
  Quantum Biopharma Ltd. filed a Form 6-K on March 27, 2026, reporting information as a foreign issuer. The filing includes a press release as an exhibit, but no
• Quantum Biopharma Files Routine 6-K Report on March 26, 2026 — Mar 26, 2026
  Quantum Biopharma Ltd. filed a 6-K on March 26, 2026, indicating a routine report for a foreign issuer. This filing, with accession number 0001171843-26-001926,
• 6-K Filing — Dec 23, 2025
• Quantum Biopharma Ltd. Files December 2025 6-K Report — Dec 22, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on December 22, 2025, for the month of December 2025. The company, incorporated in A6 and hea
• 6-K Filing — Dec 22, 2025
• 6-K Filing — Dec 8, 2025
• 6-K Filing — Dec 1, 2025
• Quantum Biopharma Ltd. Files 6-K Report — Nov 28, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on November 28, 2025, reporting for the month of November 2025. The company, incorporated in
• 6-K Filing — Nov 26, 2025
• 6-K Filing — Nov 25, 2025
• 6-K Filing — Nov 7, 2025
• Quantum Biopharma Files 6-K Report — Nov 6, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on November 6, 2025, reporting for the period ending September 30, 2025. The filing is a repo
• 6-K Filing — Nov 3, 2025
• Quantum Biopharma Ltd. Files Form 6-K — Oct 29, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on October 29, 2025, reporting for the month of October 2025. The company, incorporated in A6
• Quantum Biopharma Ltd. Files October 2025 6-K Report — Oct 23, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on October 23, 2025. The company, incorporated in A6 and headquartered in Toronto, Ontario, i
• Quantum Biopharma Ltd. Files 6-K Report — Oct 20, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on October 20, 2025. The company, incorporated in A6 with its principal executive office in T
• Quantum Biopharma Ltd. Files October 2025 6-K Report — Oct 14, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on October 14, 2025. The company, incorporated in A6 with its principal executive offices in
• Quantum Biopharma Files 6-K Report — Oct 8, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on October 8, 2025. The company, incorporated in A6 with its principal executive office in To
• Quantum Biopharma Ltd. Files October 2025 6-K Report — Oct 3, 2025 Risk: low
  Quantum Biopharma Ltd. filed a Form 6-K on October 3, 2025, reporting for the month of October 2025. The company, formerly known as FSD Pharma Inc. until March
• Quantum Biopharma Files October 2025 6-K Report — Oct 2, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on October 2, 2025. The company, incorporated in A6 and headquartered in Toronto, Ontario, is
• Quantum Biopharma Ltd. Files October 2025 6-K Report — Oct 1, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on October 1, 2025, for the month of October 2025. The company, incorporated in A6 and headqu
• Quantum Biopharma Ltd. Files September 2025 6-K Report — Sep 29, 2025 Risk: low
  Quantum Biopharma Ltd. filed a Form 6-K on September 29, 2025, reporting for the month of September 2025. The company, formerly known as FSD Pharma Inc. until M
• Quantum Biopharma Ltd. Files September 2025 6-K Report — Sep 24, 2025 Risk: low
  Quantum Biopharma Ltd. filed a Form 6-K on September 24, 2025, reporting for the month of September 2025. The company, formerly known as FSD Pharma Inc. until M
• Quantum Biopharma Ltd. Files 6-K Report — Sep 18, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on September 18, 2025, reporting for the month of September 2025. The company, incorporated i
• Quantum Biopharma Ltd. Files Form 6-K — Sep 12, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on September 12, 2025. The company, incorporated in A6 and headquartered in Toronto, Canada,
• Quantum Biopharma Files 6-K Report — Sep 10, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on September 10, 2025, reporting for the month of September 2025. The company, incorporated i
• Quantum Biopharma Ltd. Files August 2025 6-K Report — Aug 21, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on August 21, 2025. The company, incorporated in A6 and headquartered in Toronto, Canada, is
• Quantum Biopharma Ltd. Files August 2025 6-K Report — Aug 11, 2025 Risk: low
  Quantum Biopharma Ltd. filed a Form 6-K on August 11, 2025, reporting for the month of August 2025. The company, formerly known as FSD Pharma Inc. until March 2
• Quantum Biopharma Ltd. Files August 2025 6-K Report — Aug 8, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on August 8, 2025. The company, incorporated in A6 with its principal executive office in Tor
• Quantum Biopharma Ltd. Files 6-K Report — Aug 7, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on August 7, 2025, for the period ending June 30, 2025. The report includes exhibits 99.1 and
• Quantum Biopharma Ltd. Files August 2025 6-K Report — Aug 7, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on August 7, 2025, reporting for the month of August 2025. The company, incorporated in A6 an
• Quantum Biopharma Ltd. Files Form 6-K — Aug 5, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on August 5, 2025. The company, incorporated in A6 with its principal executive office in Tor
• Quantum Biopharma Ltd. Files August 2025 6-K Report — Aug 4, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on August 4, 2025, reporting for the month of August 2025. The company, incorporated in A6 an
• Quantum Biopharma Ltd. Files July 2025 6-K Report — Jul 31, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on July 31, 2025. The company, headquartered in Toronto, Canada, is reporting for the month o
• Quantum Biopharma Ltd. Files Form 6-K — Jul 22, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on July 22, 2025. The company, incorporated in A6 with its principal executive office in Toro
• Quantum Biopharma Ltd. Files 6-K Report — Jul 8, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on July 8, 2025. The company, incorporated in A6 with its principal executive office in Toron
• Quantum Biopharma Ltd. Files June 2025 6-K Report — Jun 27, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on June 27, 2025. The company, incorporated in A6 and headquartered in Toronto, Canada, opera
• Quantum Biopharma Ltd. Files June 2025 6-K Report — Jun 26, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on June 26, 2025. The company, incorporated in A6 with its principal executive office in Toro
• Quantum Biopharma Ltd. Files June 2025 6-K Report — Jun 17, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on June 17, 2025, reporting for the month of June 2025. The company, incorporated in A6 with
• Quantum Biopharma Ltd. Files June 2025 6-K Report — Jun 13, 2025 Risk: low
  Quantum Biopharma Ltd. filed a Form 6-K on June 13, 2025, reporting as a foreign private issuer for the month of June 2025. The company, formerly known as FSD P
• Quantum Biopharma Ltd. Files June 2025 6-K Report — Jun 10, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on June 10, 2025, reporting for the month of June 2025. The company, incorporated in A6 and h
• Quantum Biopharma Ltd. Files June 2025 6-K Report — Jun 3, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on June 3, 2025, reporting for the month of June 2025. The company, incorporated in A6 and he
• Quantum Biopharma Ltd. Files May 2025 6-K Report — May 30, 2025 Risk: low
  Quantum Biopharma Ltd. filed a Form 6-K on May 30, 2025, reporting for the month of May 2025. The company, formerly known as FSD Pharma Inc. until March 27, 201
• Quantum Biopharma Ltd. Files 6-K Report — May 29, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on May 29, 2025. The company, incorporated in A6 with its fiscal year ending December 31, is
• Quantum Biopharma Ltd. Files May 2025 6-K Report — May 28, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc. as of March 27, 2019) filed a Form 6-K on May 28, 2025. The filing is a Report of Foreign Private Issuer for th
• Quantum Biopharma Ltd. Files May 2025 6-K Report — May 21, 2025 Risk: low
  Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on May 21, 2025. The company, incorporated in A6 with its principal executive office in Toron

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX